Avenir Corporation’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.47M | Buy |
5,058,537
+13,619
| +0.3% | +$17.4K | 0.67% | 22 |
|
2025
Q1 | $5.04M | Buy |
5,044,918
+1,950,972
| +63% | +$1.95M | 0.53% | 23 |
|
2024
Q4 | $2.82M | Buy |
3,093,946
+118,387
| +4% | +$108K | 0.29% | 28 |
|
2024
Q3 | $4.46M | Buy |
2,975,559
+5,297
| +0.2% | +$7.95K | 0.45% | 23 |
|
2024
Q2 | $2.09M | Sell |
2,970,262
-202,434
| -6% | -$142K | 0.2% | 26 |
|
2024
Q1 | $3.01M | Buy |
3,172,696
+121,294
| +4% | +$115K | 0.26% | 25 |
|
2023
Q4 | $3.39M | Buy |
3,051,402
+334,005
| +12% | +$371K | 0.29% | 23 |
|
2023
Q3 | $5.11M | Sell |
2,717,397
-2,335
| -0.1% | -$4.39K | 0.48% | 23 |
|
2023
Q2 | $9.76M | Buy |
2,719,732
+164,179
| +6% | +$589K | 0.86% | 20 |
|
2023
Q1 | $8.61M | Buy |
2,555,553
+108,464
| +4% | +$366K | 0.81% | 20 |
|
2022
Q4 | $3.79M | Buy |
2,447,089
+132,235
| +6% | +$205K | 0.38% | 24 |
|
2022
Q3 | $3.15M | Buy |
2,314,854
+149,855
| +7% | +$204K | 0.33% | 25 |
|
2022
Q2 | $4.74M | Sell |
2,164,999
-11,510
| -0.5% | -$25.2K | 0.45% | 25 |
|
2022
Q1 | $6.94M | Buy |
2,176,509
+389,234
| +22% | +$1.24M | 0.55% | 25 |
|
2021
Q4 | $7.49M | Buy |
1,787,275
+391,890
| +28% | +$1.64M | 0.58% | 23 |
|
2021
Q3 | $11.3M | Buy |
1,395,385
+28,836
| +2% | +$234K | 0.95% | 22 |
|
2021
Q2 | $10.3M | Buy |
1,366,549
+1,007,679
| +281% | +$7.61M | 0.82% | 24 |
|
2021
Q1 | $3.12M | Buy |
358,870
+152,130
| +74% | +$1.32M | 0.27% | 30 |
|
2020
Q4 | $1.65M | Buy |
206,740
+16,500
| +9% | +$132K | 0.16% | 38 |
|
2020
Q3 | $1.52M | Buy |
190,240
+22,520
| +13% | +$180K | 0.16% | 38 |
|
2020
Q2 | $1.66M | Buy |
167,720
+17,120
| +11% | +$169K | 0.19% | 37 |
|
2020
Q1 | $1.16M | Hold |
150,600
| – | – | 0.16% | 41 |
|
2019
Q4 | $580K | Hold |
150,600
| – | – | 0.06% | 54 |
|
2019
Q3 | $758K | Buy |
150,600
+5,300
| +4% | +$26.7K | 0.08% | 52 |
|
2019
Q2 | $960K | Buy |
145,300
+58,060
| +67% | +$384K | 0.1% | 49 |
|
2019
Q1 | $660K | Buy |
87,240
+10,850
| +14% | +$82.1K | 0.07% | 52 |
|
2018
Q4 | $617K | Buy |
76,390
+34,135
| +81% | +$276K | 0.08% | 52 |
|
2018
Q3 | $545K | Buy |
42,255
+11,185
| +36% | +$144K | 0.06% | 56 |
|
2018
Q2 | $354K | Buy |
+31,070
| New | +$354K | 0.04% | 60 |
|